Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transradial vs Transfemoral Group-Randomized Efficacy and Safety Trial for Cerebral Angiography：A Prospective, Multicenter, Cluster-Randomized Controlled, Open-Label, Blinded Endpoint Evaluation Study（TARGET-CA）

NCT07544043 is registered in ClinicalTrials.gov with Gansu Provincial Maternal and Child Health Care Hospital as lead sponsor.

NCT NCT07544043
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07544043 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transradial vs Transfemoral Group-Randomized Efficacy and Safety Trial for Cerebral Angiography：A Prospective, Multicenter, Cluster-Randomized Controlled, Open-Label, Blinded Endpoint Evaluation Study（TARGET-CA）
Lead sponsor
Gansu Provincial Maternal and Child Health Care Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
May 1, 2026
Completion date
May 1, 2027
Enrollment
2,473 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cerebrovascular disease